4d Molecular Therapeutics In shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $331k | 31k | 10.84 |
| 2024-06-30 | $631k | 30k | 21.00 |
| 2024-03-31 | $764k | 24k | 31.90 |
| 2023-12-31 | $458k | 23k | 20.27 |
| 2023-09-30 | $274k | 22k | 12.75 |
| 2023-06-30 | $342k | 19k | 18.08 |
| 2023-03-31 | $316k | 18k | 17.19 |
| 2022-12-31 | $386k | 17k | 22.21 |
| 2022-03-31 | $172k | 11k | 15.12 |
| 2021-12-31 | $234k | 11k | 21.92 |
| 2021-03-31 | $12M | 280k | 43.38 |
| 2020-12-31 | $14M | 344k | 41.45 |